Tagris Bio

塔吉瑞生物

Tagris Bio

Biotech/Healthcare

Targene is a novel drug developer with internationally leading technologies. The company focuses on addressing acquired drug resistance in cancer and develops next-generation, patent-protected, small-molecule targeted therapies.

Latest round: Series B (2022)

Source: ChinaBulls — chinabulls.com

Last updated 2022-07-01